HOME > NATIONAL > Article

Text Size

small

medium

large


Osaka Univ. Team Develops Immune Cell Therapy for AML

Osaka Univ. Team Develops Immune Cell Therapy for AML

   Osaka, May 8 (Jiji Press)--A group of researchers at Japan's University of Osaka has developed a new immune cell therapy that could be applied to patients of acute myeloid leukemia, or AML, a type of hematological cancer.
   Many AML patients die of cancer recurrence even after receiving bone marrow transplants and other treatments. The new therapy could save such patients once it is put into practical application, the team said.
   The results of the study were published in an online edition of an international academic journal.
   Under the new therapy, immune cells that attack cancer cells are taken from the blood of AML patients themselves or the umbilical cord blood of other individuals. The cells are multiplied outside the patients' bodies and then administered to them. The therapy is already in practical use for patients of acute lymphocytic leukemia and malignant lymphoma.
   The team created some 14,000 antibodies against AML cells and discovered cells from among them that attack only AML cells without damaging other cells.

To read a full story, please click here to find out how to subscribe.

NATIONAL

HEADLINES

POLITICS
Govt, LDP Likely to Skip Consumption Tax Cut in Steps against Inflation, Tariffs
ECONOMY
Nippon Steel Expects 42.9% Dive in FY 2025 Net Profit, Bracing for Tariff Impact
SPORTS
Outgoing IOC Pres. Bach Visits JOC, Expresses Gratitude for Years of Support
OTHER
Japan's Princess Aiko Visits Foreign Pavilions at World Exposition in Osaka

AFP-JIJI PRESS NEWS JOURNAL


Photos